Cart
sales@molnova.com
4-Oxofenretinide
CAS No. 865536-65-8
4-Oxofenretinide( 4-Oxo-4-HPR | 4-Oxo Fenretinide | 4-Keto-4-HPR )
Catalog No. M17628 CAS No. 865536-65-8
4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 2MG | 48 | In Stock |
|
| 5MG | 68 | In Stock |
|
| 10MG | 109 | In Stock |
|
| 25MG | 195 | In Stock |
|
| 50MG | 286 | In Stock |
|
| 100MG | 517 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Oxofenretinide
-
NoteResearch use only, not for human use.
-
Brief Description4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis.
-
Description4-Oxo-4-HPR is an inhibitor of tubulin polymerization, inducing marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. It is also a fenretinide metabolite.
-
In Vitro——
-
In Vivo——
-
Synonyms4-Oxo-4-HPR | 4-Oxo Fenretinide | 4-Keto-4-HPR
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
Recptorcell cycle arrest and apoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number865536-65-8
-
Formula Weight405.53
-
Molecular FormulaC26H31NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C(C(CCC1=O)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)Nc1ccc(cc1)O)/C)/C
-
Chemical Name(2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Villani MG,et al. Cancer Res. 2006 Mar 15;66(6):3238-47.
molnova catalog
related products
-
Darbufelone
Darbufelone is a dual inhibitor of cellular PGF2α and LTB4 production.
-
MF-766
MF-766 is a highly potent, selective and orally active EP4 antagonist with a Ki of 0.23 nM. It behaves as a full antagonist with an IC50 of 1.4 nM (shifted to 1.8 nM in the presence of 10% HS) in the functional assay. It can be used for cancer and inflammation diseases research.
-
Grapiprant
A novel EP4 antagonist; an analgesic and anti-inflammatory drug in the piprant class that was approved for Veterinary Medicine for the control of pain and inflammation.
